Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in the AUVA Research Center, Vienna, Austria.
Rhode Island Hospital and Alpert School of Medicine at Brown University, Providence, Rhode Island.
Shock. 2018 Oct;50(4):377-380. doi: 10.1097/SHK.0000000000001212.
Preclinical animal studies precede the majority of clinical trials. While the clinical definitions of sepsis and recommended treatments are regularly updated, a systematic review of preclinical models of sepsis has not been done and clear modeling guidelines are lacking. To address this deficit, a Wiggers-Bernard Conference on preclinical sepsis modeling was held in Vienna in May, 2017. The goal of the conference was to identify limitations of preclinical sepsis models and to propose a set of guidelines, defined as the "Minimum Quality Threshold in Preclinical Sepsis Studies" (MQTiPSS), to enhance translational value of these models. A total of 31 experts from 13 countries participated and were divided into six thematic Working Groups: Study Design, Humane modeling, Infection types, Organ failure/dysfunction, Fluid resuscitation, and Antimicrobial therapy endpoints. As basis for the MQTiPSS discussions, the participants conducted a literature review of the 260 most highly cited scientific articles on sepsis models (2002-2013). Overall, the participants reached consensus on 29 points; 20 at "recommendation" and nine at "consideration" strength. This Executive Summary provides a synopsis of the MQTiPSS consensus. We believe that these recommendations and considerations will serve to bring a level of standardization to preclinical models of sepsis and ultimately improve translation of preclinical findings. These guideline points are proposed as "best practices" for animal models of sepsis that should be implemented. To encourage its wide dissemination, this article is freely accessible on the Intensive Care Medicine Experimental and Infection journal websites. In order to encourage its wide dissemination, this article is freely accessible in Shock, Infection, and Intensive Care Medicine Experimental.
临床前动物研究先于大多数临床试验。虽然脓毒症的临床定义和推荐的治疗方法经常更新,但尚未对脓毒症的临床前模型进行系统审查,也缺乏明确的建模指南。为了解决这一不足,2017 年 5 月在维也纳举行了一次临床前脓毒症建模威格尔斯-伯纳德会议。会议的目标是确定临床前脓毒症模型的局限性,并提出一套指南,定义为“临床前脓毒症研究的最低质量阈值”(MQTiPSS),以提高这些模型的转化价值。共有来自 13 个国家的 31 名专家参加了会议,并分为六个专题工作组:研究设计、人性化建模、感染类型、器官衰竭/功能障碍、液体复苏和抗菌治疗终点。作为 MQTiPSS 讨论的基础,与会者对 260 篇脓毒症模型的高引用科学文章(2002-2013 年)进行了文献回顾。总体而言,与会者就 29 个要点达成了共识;20 个是“建议”,9 个是“考虑”。本执行摘要提供了 MQTiPSS 共识的概述。我们相信,这些建议和考虑将有助于为临床前脓毒症模型带来标准化水平,并最终改善临床前发现的转化。这些指南要点被提议作为脓毒症动物模型的“最佳实践”,应该实施。为了鼓励其广泛传播,本文在重症监护医学实验与感染杂志网站上免费开放。为了鼓励其广泛传播,本文在 Shock、Infection 和 Intensive Care Medicine Experimental 杂志上免费开放。